AERAS  [to 1 Sep 2018]
No new digest content identified.
BMGF – Gates Foundation  [to 1 Sep 2018]
No new digest content identified.

Bill & Melinda Gates Medical Research Institute    [to 1 Sep 2018]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X   [to 1 Sep 2018]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations  [to 1 Sep 2018]
Posted on 20TH AUG 2018 by Mario Christodoulou
CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine
OSLO (Norway), Dessau-Rosslau, (Germany)
CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a collaboration with IDT Biologika under which IDT will receive up to USD$36 million to advance the development and manufacture of a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a zoonotic disease that is spread to humans from dromedary camels.
Under the terms of the Framework Partnering Agreement for the collaboration, IDT will receive development funding from CEPI for advancing its MERS-CoV vaccine. CEPI will provide $15.7 million to support the first stages of the development, with options to invest up to a total of $36 million over 5 years (including clinical development, process development, manufacturing, and stockpile of the vaccine)…

EDCTP    [to 1 Sep 2018]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

Emory Vaccine Center    [to 1 Sep 2018]
No new digest content identified.

European Medicines Agency  [to 1 Sep 2018]
Development of medicines for rare diseases
An overview of the EU’s orphan designation programme …

Towards improving the availability of medicines in the EU
EU-wide task force publishes work programme 2019/20 and prepares multi-stakeholder workshop …

Fostering medicines for children
At a glance: EMA’s support of paediatric research …
European Vaccine Initiative  [to 1 Sep 2018]
No new digest content identified.
FDA [to 1 Sep 2018]
No new digest content identified.

Fondation Merieux  [to 1 Sep 2018]
No new digest content identified.

Gavi [to 1 Sep 2018]
01 September 2018
Measles vaccine campaign launched in Afghanistan
Kabul, Afghanistan – The Government of Afghanistan, in collaboration with the United Nations Children’s Fund (UNICEF), the World Health Organization (WHO) and Gavi, the Vaccine Alliance, have today launched a nationwide vaccination campaign to protect children 13.8 million children aged 9 months to 10 years against measles…

GHIT Fund   [to 1 Sep 2018]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.

Global Fund [to 1 Sep 2018];&country=
Global Fund Appoints Fady Zeidan as General Counsel
31 August 2018
Hilleman Laboratories   [to 1 Sep 2018]
No new digest content identified.
Human Vaccines Project   [to 1 Sep 2018]
No new digest content identified.
IAVI  [to 1 Sep 2018]
No new digest content identified.

No new digest content identified.

IVAC  [to 1 Sep 2018]
August 2018
Bill Moss on the Increase in Measles Cases in Europe
To talk about the increase in measles cases in some parts of the world, Dr. Bill Moss, Deputy Director of the International Vaccine Access Center, joined a program called the Show hosted by KJZZ, an NPR member station in Phoenix, Arizona.
IVI   [to 1 Sep 2018]
KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera
– Joint initiative aims to prevent and control cholera, and secure sustainable cholera and diarrheal disease surveillance
– WASH campaign to promote access to clean water and behavioral change for appropriate sanitation and hygiene practice
– “KOICA is joining the program to contribute to ‘Ending Cholera—A Global Roadmap to 2030’”

JEE Alliance  [to 1 Sep 2018]
No new digest content identified.
MSF/Médecins Sans Frontières  [to 1 Sep 2018]
Selected Press Releases/Statements
Central African Republic
Suffering mounts as armed groups return to Bambari
Project Update 31 Aug 2018

Conflict in Tripoli puts lives in danger, demonstrating that Libya is not a place of safety
Press Release31 August 2018

NIH  [to 1 Sep 2018]
August 31, 2018
Novel intervention halves rate of death among people living with HIV who inject drugs
— NIH-supported study finds intervention boosts treatment participation, HIV suppression.

NIH names Dr. Helene Langevin director of the National Center for Complementary and Integrative Health
August 29, 2018 — Dr. Langevin is expected to join NIH in November 2018.

HIV/AIDS research yields dividends across medical fields
August 28, 2018 — Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other diseases.

PATH  [to 1 Sep 2018]
No new digest content identified.

Sabin Vaccine Institute  [to 1 Sep 2018]
Rotavirus Experts Share Latest Research, Call for Increased Vaccine Coverage at Symposium
Wednesday, August 29, 2018
MINSK, BELARUS – Beginning today, the 13th International Rotavirus Symposium, hosted by the Sabin Vaccine Institute, the U.S. Centers for Diseases Control, PATH, ROTA Council, the Fogarty International Center at the U.S. National Institutes of Health, the Government of the Republic of Belarus, and the Bill & Melinda Gates Foundation, is bringing together scientific experts, policy makers and public health officials to share the latest developments in the fast-moving field of rotavirus prevention. Attendees of the three-day Symposium will examine the latest results from new rotavirus vaccine trials and studies around the globe, with a special focus on the impact of rotavirus vaccine introduction on childhood diarrheal illness, advances in immunology and virology, the factors that enable or inhibit national decisions for vaccine introduction, issues in vaccine policy, and vaccine financing and safety.
The biennial International Rotavirus Symposium provides a crucial opportunity for researchers and national public health officials to discuss approaches to further reduce the global morbidity and mortality associated with rotavirus…
UNAIDS [to 1 Sep 2018]
28 August 2018
Botswana to revitalize HIV combination prevention

27 August 2018
Situation rooms bring actionable data to decision-makers
Health situation rooms—software platforms designed to support decision-making on countries’ health responses—are opening up across Africa, bridging data and decision-making in order to improve the health and lives of tens of millions of the world’s most vulnerable people.
Data integration, data warehousing and data visualization are the core of the situation room concept, providing transparent and improved information on a range of diseases. While situation rooms are virtual working space, some countries also use physical rooms in which the analytics can be discussed and acted upon…

UNICEF  [to 1 Sep 2018]
Selected Press Releases/Reports/Statements
Press release   31/08/2018
Children among most vulnerable as extreme weather events continue around the world
Record heatwaves, floods and droughts ‘a stark vision of the world we are creating for future generations’

Press release   28/08/2018
UNICEF steps-up support for children ahead of new school year in Ebola affected areas of Eastern DRC

Vaccine Confidence Project  [to 1 Sep 2018]
No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to 1 Sep 2018]
No new digest content identified.
Wellcome Trust  [to 1 Sep 2018]
Published: 30 August 2018
Public engagement: it’s fantastic for research, but how feasible is it for you?
In the third in our blog series from the Public Engagement team, Imran Khan and Rebecca Jones talk about the issues around researcher-led public engagement. 
Is engagement seen as part of the job of being a Wellcome researcher, or as an add-on in a growing list of demands? Is academic culture continuing to be more open and public, or have we taken our eye off the ball and let progress stall? Do funders reward good practice when we see it, or just complain about it when we don’t?
These are some of the questions we’re asking ourselves as we try to figure out how best to involve Wellcome-funded researchers in our new public engagement strategy.
Wellcome funding supports over 14,000 people in over 70 countries, so finding ways to make sure our grantees’ work is shared with the public is one of our team’s biggest opportunities – and biggest challenges…
The Wistar Institute   [to 1 Sep 2018]
No new digest content identified.

World Organisation for Animal Health (OIE)   [to 1 Sep 2018]
No new digest content identified.

BIO    [to 1 Sep 2018]
No new digest content identified.

DCVMN – Developing Country Vaccine Manufacturers Network  [to 1 Sep 2018]
No new digest content identified.

IFPMA   [to 1 Sep 2018]
No new digest content identified.

PhRMA    [to 1 Sep 2018]
No new digest content identified.